UNIVERSITY OF MIAMI

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: https://continue.miami.edu/packagedetail.aspx

Clinical Trials

Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma

Phase 2

Active, not recruiting

Conditions: Mantle-Cell Lymphoma

Interventions: Biological: G-CSF
Drug: Rituximab
Drug: Cyclophosphamide
Drug: Cytarabine
Drug: Doxorubicin
Drug: Etoposide
Drug: Ifosfamide
Drug: Leucovorin
Drug: Mesna
Drug: Methotrexate
Drug: Vincristine

First Posted Date: 2009-04-08

Last Posted Date: 2024-07-03

Lead Sponsor: University of Miami

Target Recruit Count: 25

Registration Number: NCT00878254

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Phase 2

Completed

Conditions: Liver Cancer

Interventions: Drug: Carboplatin
Drug: Cisplatin
Drug: Sorafenib

First Posted Date: 2009-04-03

Last Posted Date: 2017-02-07

Lead Sponsor: University of Miami

Target Recruit Count: 11

Registration Number: NCT00875615

Locations: 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States

Parent Educational Program for Children With Sickle Cell Disease

Not Applicable

Completed

Conditions: Hemoglobin SC Disease
Anemia, Sickle Cell

Interventions: Behavioral: Parent Educational Support

First Posted Date: 2009-03-12

Last Posted Date: 2021-08-02

Lead Sponsor: University of Miami

Target Recruit Count: 73

Registration Number: NCT00860782

Locations: 🇺🇸
Mailman Center for Child Development, Miami, Florida, United States

Racial Differences in Phosphorus Metabolism

Not Applicable

Completed

Conditions: Control

Interventions: Drug: 1-34 parathyroid infusion

First Posted Date: 2009-03-06

Last Posted Date: 2017-09-11

Lead Sponsor: University of Miami

Target Recruit Count: 26

Registration Number: NCT00856726

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

Phase 4

Terminated

Conditions: Lymphoma
Precancerous/Nonmalignant Condition

Interventions: Biological: PEG-interferon alfa-2b
Biological: Interferon alfa-2b
Drug: Zidovudine
Drug: Valproic Acid

First Posted Date: 2009-03-03

Last Posted Date: 2018-04-17

Lead Sponsor: University of Miami

Target Recruit Count: 13

Registration Number: NCT00854581

Locations: 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States

Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response

Phase 2

Completed

Conditions: Phenylketonuria

Interventions: Drug: Kuvan
Other: Diet

First Posted Date: 2009-02-11

Last Posted Date: 2019-12-03

Lead Sponsor: University of Miami

Target Recruit Count: 21

Registration Number: NCT00841100

Locations: 🇺🇸
Department of Biochemistry & Molecular Biology, Miami, Florida, United States

Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema

Phase 1

Completed

Conditions: Uveitic Cystoid Macular Edema

Interventions: Drug: ranibizumab

First Posted Date: 2009-01-22

Last Posted Date: 2014-08-26

Lead Sponsor: University of Miami

Target Recruit Count: 6

Registration Number: NCT00826618

Locations: 🇺🇸
Bascom Palmer Eye Insitute, Miami, Florida, United States
🇺🇸
Bascom Palmer of the Palm Beaches, Palm Beach Gardens, Florida, United States

Rapid HIV Testing and Counseling in Drug Abuse Treatment

Phase 3

Completed

Conditions: Substance-Related Disorders

Interventions: Behavioral: On- site HIV rapid test & information
Behavioral: Referral for off-site HIV testing
Behavioral: On-site HIV rapid test and brief, prevention counseling

First Posted Date: 2008-12-17

Last Posted Date: 2015-10-14

Lead Sponsor: University of Miami

Target Recruit Count: 1281

Registration Number: NCT00809445

Locations: 🇺🇸
Chesterfield CSB Substance Abuse Service, Chesterfield, Virginia, United States
🇺🇸
Daymark Recovery Services, Inc., Salisbury, North Carolina, United States
🇺🇸
Wheeler Clinic, Plainville, Connecticut, United States

and more 9 locations

Timing of PDA Closure and Respiratory Outcome in Premature Infants

Not Applicable

Terminated

Conditions: Patent Ductus Arteriosus

Interventions: Drug: Early ibuprofen
Other: Late ibuprofen expectant group (placebo)

First Posted Date: 2008-12-05

Last Posted Date: 2014-02-05

Lead Sponsor: University of Miami

Target Recruit Count: 105

Registration Number: NCT00802685

Locations: 🇺🇸
Jackson Memorial Hospital/Holtz Children's Center, Miami, Florida, United States

Vasopressin Versus Catecholamines for Cerebral Perfusion Pressure Control in Brain Injured Trauma Patients

Not Applicable

Completed

Conditions: Traumatic Brain Injury

Interventions: Drug: Standard catecholamine
Drug: arginine vasopressin

First Posted Date: 2008-11-21

Last Posted Date: 2014-12-12

Lead Sponsor: University of Miami

Target Recruit Count: 96

Registration Number: NCT00795366

Locations: 🇺🇸
Ryder Trauma Center, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy